+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acromegaly Drug"

Global Acromegaly Treatment Market by Disease Type (Ectopic Acromegaly, Pseudo Acromegaly), Drug Class (Bromocriptine Mesylate (Parlodel), Dopamine Agonists, Growth Hormone Receptor Antagonist), Distribution Channel, End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Acromegaly Treatment Market by Disease Type (Ectopic Acromegaly, Pseudo Acromegaly), Drug Class (Bromocriptine Mesylate (Parlodel), Dopamine Agonists, Growth Hormone Receptor Antagonist), Distribution Channel, End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 194 Pages
  • Global
From
Global Acromegaly Treatment Market Size, Share & Trends Analysis Report by Drug Type (Somatostatin Analogs, GHRA), End-use (Hospitals & Clinics), Region, and Segment Forecasts, 2023-2030 - Product Thumbnail Image

Global Acromegaly Treatment Market Size, Share & Trends Analysis Report by Drug Type (Somatostatin Analogs, GHRA), End-use (Hospitals & Clinics), Region, and Segment Forecasts, 2023-2030

  • Report
  • December 2023
  • 100 Pages
  • Global
From
Acromegaly - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Acromegaly - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2023
  • 147 Pages
  • Global
From
Acromegaly - Pipeline Insight, 2024 - Product Thumbnail Image

Acromegaly - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acromegaly Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

Acromegaly Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 182 Pages
  • Global
From
Acromegaly Global Market Report 2024 - Product Thumbnail Image

Acromegaly Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Acromegaly Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Acromegaly Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Somatostatin Analogs Market Size, Share & Trends Analysis Report By Type (Octreotide, Lanreotide, Pasireotide), By Application (Acromegaly, Neuroendocrine Tumors), By Region And Segment Forecasts, 2019 - 2026 - Product Thumbnail Image

Somatostatin Analogs Market Size, Share & Trends Analysis Report By Type (Octreotide, Lanreotide, Pasireotide), By Application (Acromegaly, Neuroendocrine Tumors), By Region And Segment Forecasts, 2019 - 2026

  • Report
  • October 2019
  • 90 Pages
  • Global
From
Acromegaly Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Acromegaly Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 105 Pages
  • Global
From
Acromegaly - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acromegaly - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acromegaly Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Acromegaly Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • May 2018
  • 83 Pages
  • Global
From
US Acromegaly Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Acromegaly Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Acromegaly Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Acromegaly Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Europe Acromegaly Market and Competitive Landscape - 2021 - Product Thumbnail Image

Europe Acromegaly Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Europe
From
Global Acromegaly Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Acromegaly Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Global
From
Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • August 2022
  • 168 Pages
  • Global
From
Acromegaly and Gigantism - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Acromegaly and Gigantism - Global Drug Forecast and Market Analysis to 2029

  • Report
  • November 2020
  • 225 Pages
  • Global
From
Acromegaly Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Acromegaly Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 163 Pages
  • Global
From
Somatostatin Receptor Type 4 - Pipeline Review, H2 2020 - Product Thumbnail Image

Somatostatin Receptor Type 4 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 39 Pages
  • Global
From
Acromegaly - Pipeline Review, H2 2020 - Product Thumbnail Image

Acromegaly - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 96 Pages
  • Global
From
Loading Indicator

The Acromegaly Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It is composed of drugs used to treat acromegaly, a condition caused by an excess of growth hormone. These drugs are used to reduce the production of growth hormone, reduce its effects, or both. Commonly used drugs include somatostatin analogs, dopamine agonists, and GH receptor antagonists. Surgery is also an option for some patients. The Acromegaly Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Novartis, Pfizer, Ipsen, and Teva Pharmaceuticals. Other companies include Sandoz, Merck, and Eli Lilly. Show Less Read more